Tag Archives: C (Linda) MC van Campen

Cerebral blood flow is reduced in severe ME/CFS patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing

Posted on 06/17/2020 by wames

Cerebral blood flow is reduced in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing, by C (Linda) MC van Campen, Peter C Rowe  and Frans C Visser in … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Cerebral blood flow is reduced in severe ME/CFS patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing

Heart rate thresholds to limit activity in ME/CFS patients (pacing): comparison of heart rate formulae

Posted on 05/26/2020 by wames

Heart rate thresholds to limit activity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients (Pacing): Comparison of heart rate formulae and measurements of the heart rate at the lactic acidosis threshold during Cardiopulmonary Exercise Testing, by C (Linda) MC van Campen, Peter … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Heart rate thresholds to limit activity in ME/CFS patients (pacing): comparison of heart rate formulae

The effect of curcumin in patients with CFS/ME

Posted on 12/06/2019 by wames

The effect of curcumin in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis disparate responses in different disease severities, by C (Linda) MC van Campen and Frans C Visser in Pharmacovigil and Pharmacoepi  Vol 2 Issue 1, pages 6, Nov 19, 2019 … Continue reading →

Posted in News | Tagged , , , , | Comments Off on The effect of curcumin in patients with CFS/ME